Article By:
InvestInMJ
Monday, January 30, 2017 3:00 PM EDT
We recently had the pleasure to speak to Robert Brooke, the CEO of Vitality Biopharma, a publicly traded pharmaceutical company focused on cannabis based medical drugs, and their recent R&D breakthrough for those suffering from IBD & Crohn's Disease.
Interview With Vitality Biopharma Inc.
Any updates on $VBIO?
Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
I picked up some $VBIO but it hasn't done well for me since. But it's a longer-term play. I'm not expecting a quick flip.
Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.
www.talkmarkets.com/.../interview-with-vitality-biopharma-inc
Not a lot of info on the company though.
Interview With Vitality Biopharma Inc.
Thanks for the interview, InvestInMJ. Happy to answer any readers' questions on #VitalityBiopharma. $VBIO
Interview With Vitality Biopharma Inc.
I'm in for some $VBIO
Interview With Vitality Biopharma Inc.
InvestInMJ, how can we get a copy of your newsletter once you have more info? Thanks. $VBIO.
Interview With Vitality Biopharma Inc.
Definitely going to take a closer look at $VBIO, thanks.
Interview With Vitality Biopharma Inc.
Very impressive InvestInMJ. So would you recommend picking up some shares of $VBIO? Did you purchase it?
Interview With Vitality Biopharma Inc.
This company looks very promising. I have to admit, I haven't heard of #VitalityBiopharma before but will be doing more due diligence on the stock and will consider adding it to my portfolio. $VBIO.
Vitality Biopharma Taking Cannabinoid Research To The Next Level
Logical One 's accusations about this stock are very disconcerting! Jason Napodano, as the author of this piece, do you have anything else to say about $VBIO?